全文获取类型
收费全文 | 28036篇 |
免费 | 2914篇 |
国内免费 | 984篇 |
专业分类
耳鼻咽喉 | 111篇 |
儿科学 | 293篇 |
妇产科学 | 162篇 |
基础医学 | 3586篇 |
口腔科学 | 1905篇 |
临床医学 | 2571篇 |
内科学 | 3921篇 |
皮肤病学 | 428篇 |
神经病学 | 2039篇 |
特种医学 | 3362篇 |
外国民族医学 | 2篇 |
外科学 | 2221篇 |
综合类 | 3065篇 |
现状与发展 | 3篇 |
预防医学 | 1422篇 |
眼科学 | 1191篇 |
药学 | 3304篇 |
13篇 | |
中国医学 | 1485篇 |
肿瘤学 | 850篇 |
出版年
2024年 | 29篇 |
2023年 | 490篇 |
2022年 | 645篇 |
2021年 | 1604篇 |
2020年 | 1213篇 |
2019年 | 1144篇 |
2018年 | 1180篇 |
2017年 | 1120篇 |
2016年 | 1186篇 |
2015年 | 1242篇 |
2014年 | 1983篇 |
2013年 | 2157篇 |
2012年 | 1658篇 |
2011年 | 1891篇 |
2010年 | 1497篇 |
2009年 | 1408篇 |
2008年 | 1310篇 |
2007年 | 1278篇 |
2006年 | 1112篇 |
2005年 | 1101篇 |
2004年 | 827篇 |
2003年 | 764篇 |
2002年 | 601篇 |
2001年 | 541篇 |
2000年 | 396篇 |
1999年 | 333篇 |
1998年 | 289篇 |
1997年 | 288篇 |
1996年 | 254篇 |
1995年 | 257篇 |
1994年 | 282篇 |
1993年 | 233篇 |
1992年 | 184篇 |
1991年 | 150篇 |
1990年 | 142篇 |
1989年 | 116篇 |
1988年 | 122篇 |
1987年 | 111篇 |
1986年 | 116篇 |
1985年 | 147篇 |
1984年 | 101篇 |
1983年 | 79篇 |
1982年 | 103篇 |
1981年 | 67篇 |
1980年 | 59篇 |
1979年 | 35篇 |
1978年 | 24篇 |
1977年 | 33篇 |
1976年 | 14篇 |
1975年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 25 毫秒
91.
Matthew D. Li Katrina F. Chu Allegra DePietro Vincent Wu Eric Wehrenberg-Klee Omar Zurkiya Raymond W. Liu Suvranu Ganguli 《Journal of vascular and interventional radiology : JVIR》2019,30(3):314-319
Purpose
To evaluate the feasibility of a same-day yttrium-90 (90Y) radioembolization protocol with resin microspheres (including pretreatment angiography, lung shunt fraction [LSF] determination, and radioembolization) for the treatment of hepatocellular carcinoma (HCC) and liver metastases.Materials and Methods
All same-day radioembolization procedures performed over 1 y (February 2017 to January 2018) were included in this single-institutional retrospective analysis, in which 34 procedures were performed in 26 patients (median age, 63 y; 13 women), 19 with liver metastases and 7 with HCC. Yttrium-90 treatment activities were calculated by body surface area method. Tumor imaging response was assessed by Response Evaluation Criteria In Solid Tumors (RECIST) 1.1 for liver metastases and modified RECIST for HCC. Clinical side effects and adverse events were graded per Common Terminology Criteria for Adverse Events version 4.0.Results
All planned cases were technically successful, and no cases were canceled for elevated LSF or vascular anatomic reasons. Pretreatment angiography modified the planned 90Y treatment activity in 1 case in which vascular anatomy required a lobar-dose split into 2 for segmental infusions. In 18% of cases, patients were briefly admitted after the procedure for observation or symptom management. Imaging evaluation of initial efficacy at 1 month demonstrated partial response in 25% and stable disease in 67% of patients with liver metastases and partial/complete response in 43% and stable disease in 14% of patients with HCC. Grade ≥ 3 adverse events occurred in 6% of cases, with no systemic therapy–limiting toxicities. The mean total procedure time was 4.2 hours.Conclusions
A same-day 90Y radioembolization protocol with resin microspheres is feasible in select patients, which can expedite cancer therapy. 相似文献92.
目的优化丁香苦苷聚乳酸(Syr)-羟基乙酸共聚物[poly(lactic-co-glycolic acid),PLGA]纳米粒(Syr-NPs)的处方。方法采用纳米沉淀法制备Syr-NPs,以包封率、载药量、平均粒径以及总评"归一值"为评价指标,采用星点设计-效应面法考察PLGA质量浓度(A)、丁香苦苷质量浓度(B)、水相与有机相比例(C)3因素考察对包封率、载药量、平均粒径以及总评归一值的影响,以星点设计-效应面法选取最佳处方条件进行预测分析。结果最优处方工艺为PLGA质量浓度为9.63 mg/mL,Syr质量浓度为12.88 mg/mL,有机相与水相的比例为1∶9.46,制得的Syr-NPs的包封率、载药量、平均粒径分别为(27.86±0.87)%、(7.02±0.15)%、(110.0±1.20)nm。结论该方法稳定可行,可用于优化包载Syr的PLGA纳米粒处方与制备工艺。 相似文献
93.
94.
95.
《Vaccine》2019,37(39):5854-5861
BackgroundHepatitis B virus (HBV) remains a major public health issue, although it is a vaccine-preventable disease. Adults with diabetes are at greater risk of contracting HBV than the general population. Commonly used 3-dose HBV vaccines have reduced immunogenicity in older individuals and in those with diabetes mellitus.MethodsIn this post hoc analysis of a phase 3 clinical trial, participants with type 2 diabetes mellitus aged 60–70 years received either 2-dose HBsAg/CpG 1018 (HEPLISAV-B®, n = 327) at 0 and 4 weeks and placebo at 24 weeks or 3-dose HBsAg/alum (Engerix-B®, n = 153) at 0, 4, and 24 weeks. Immunogenicity, including seroprotection rate (SPR) at week 28, and safety were assessed by subgroup (sex, body mass index, and smoking status). SPR was defined as antibody against hepatitis B surface antigen serum concentration ≥10 mIU/mL.ResultsThe SPR at week 28 was significantly higher with HBsAg/CpG 1018 (85.8% [235/274]) than with HBsAg/alum (58.5% [76/130]) in the per-protocol analysis, for an overall difference of 27.3% (95% CI, 18.0–36.8). SPRs with HBsAg/CpG 1018 were consistently markedly higher compared with HBsAg/alum, regardless of sex, body mass index, or smoking status. Adverse events and deaths were comparable between groups.ConclusionsTwo-dose HBsAg/CpG 1018 provides a higher level of seroprotection against HBV than does a 3-dose vaccine (HBsAg/alum) with a similar safety profile in patients aged 60–70 years with type 2 diabetes mellitus.Study identifier: NCT02117934. 相似文献
96.
97.
98.
99.
Sweeka Alexander Gurjeet Dulku Sharbell Hashoul Donna B Taylor 《Journal of Medical Imaging and Radiation Oncology》2019,63(4):473-478
Contrast‐enhanced spectral mammography (CESM) has a number of uses including the work‐up of inconclusive findings on mammography, assessment of breast symptoms, cancer staging, evaluation of response to neoadjuvant chemotherapy and recently as an alternative to magnetic resonance imaging (MRI) in high‐risk screening. CESM can be swiftly incorporated into the workflow of busy breast clinics. We share our experiences with CESM at a large breast assessment centre in Western Australia. 相似文献
100.
韩宝海 《中国医疗器械信息》2020,(8):122-123
心律失常是心血管系统疾病中经常出现的症状,心律失常由起源部位、心搏频率、心脏冲动传导等异常因素而引发,早发现、早确诊、早治疗对患者的健康具有重要意义。心律失常与高血压病、糖尿病、心血管病、电解质紊乱等密切相关。不同的人群、不同时期,心律失常表现也不一致,出现的频次也有不同的表现。现对本院作常规心电图、动态心电图(Holter)112例患者的结果比较进行分析。 相似文献